Nicholas Fernandez
Vermogen: 509 833 $ op 30-06-2026
Vermogen: 509 833 $ op 30-06-2026
Nicholas Fernandez is currently an Independent Director at Liminatus Pharma, Inc. since 2025.
Mr. Fernandez is also the Chief Financial Officer at JATT II Acquisition Corp.
and Amanat Acquisition Corp.
Mr. Fernandez was an Independent Director at Iris Acquisition Corp.
Mr. Fernandez was the Chief Operating & Financial Officer at Athanor Capital GP LLC.
Mr. Fernandez completed undergraduate studies at the State University of New York at Albany.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
2,3% | 20-05-2026 | 50.000 ( 2,3% ) | 508 000 $ | 30-06-2026 |
0,02% | 02-07-2026 | 16.667 ( 0,02% ) | 1 833 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|
| Bedrijven | Functie | Einde |
|---|---|---|
Athanor Capital GP LLC
Athanor Capital GP LLC Financial ConglomeratesFinance Provides investment services | Financieel Directeur/CFO | - |
| IRIS ACQUISITION A | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
State University of New York at Albany
State University of New York at Albany Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Athanor Capital GP LLC
Athanor Capital GP LLC Financial ConglomeratesFinance Provides investment services | Finance |
Iris Acquisition Corp.
Iris Acquisition Corp. Financial ConglomeratesFinance Operates as blank check company | Finance |
Kies jouw editie
Alle financiële informatie op nationaal niveau